Coste Catherine 4
4 · Renalytix plc · Filed Nov 22, 2023
Insider Transaction Report
Form 4
Renalytix plcRNLX
Coste Catherine
Director
Transactions
- Award
Employee Stock Option (right to buy)
2023-11-20+95,000→ 95,000 totalExercise: $0.30Exp: 2033-11-19→ Ordinary Shares (95,000 underlying)
Footnotes (2)
- [F1]The exercise price is 0.245 pounds sterling. The U.S. dollar equivalent of the exercise price is $0.304 using the Bank of England rate as of November 17, 2023 (1.00 pound sterling = $1.243).
- [F2]One twelfth (1/12th) of the shares subject to the option award shall vest in equal quarterly installments commencing on February 20, 2024, subject to the Reporting Person's continuous service.